Key facts
- Notable investors include Arieli Group, Horizon 2020, NGT HealthCare II.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for EndoGI Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for EndoGI Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EndoGI Medical
Developer of medical devices designed to assist in the treatment of biliary and pancreatic duct stenosis and strictures. The company's devices enable the insertion and placement of two or more stents in the common bile and hepatic ducts with one passage of the delivery system while securing and maintaining access to the guidewire at the targeted anatomical site, enabling healthcare professionals to get multiple stent placement delivery systems for improved removal of substances like a plastic stent.
- Sector
- Healthcare
- HQ
- Nazareth, Israel
- Founded
- 2017
- Employees
- 6
- Website
- endo-gi.com/
- Ownership
- Privately Held (backing)
EndoGI Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EndoGI Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EndoGI Medical in its N-PORT filings yet. We sweep new filings monthly.